• Skip to primary navigation
  • Skip to main content
  • Skip to footer

Target ALS

A New York based ALS research organization that's leading the fight for a cure.

  • DONATE
  • About Us
    • Our Mission
    • Our Impact
    • Our Team
    • Our Partners
  • For Scientists
    • Research Core Facilities
      • Longitudinal Biofluids Core
      • Human Postmortem Tissue Core
      • Genomic Datasets
      • Animal Models
      • In Vivo Target Validation Core
      • Stem Cell Core
      • Antibody Core
      • Viral Vector Core
    • Funding Opportunities
    • Funded Consortia
    • Annual Meeting
  • ALS Resources
    • The Science, Explained
    • Glossary
    • FAQ
    • Blog
    • Video Library
  • Take Action
    • Contact Us
    • Email Sign Up
    • Donate Now
    • Ways to Give
    • Donate Biofluid Samples
    • Corporate Council

Our Impact

In just seven years, our Target ALS Innovation Ecosystem has given rise to a new collaborative research community and led to the development of an array of therapeutic approaches with biological rationale.

It is a testament to the effectiveness of our Innovation Ecosystem that fosters the most promising ideas and brings together complementary minds and expertise areas to accelerate the most promising drugs toward clinical trials. Below is a snapshot of our Innovation Ecosystem at work.

175+

Research Collaborations

Hundreds of researchers with expertise in diverse areas like high-throughput functional genomics, medicinal chemistry, and stem cell biology have become committed collaborators within the ALS research community.

See Our Research Collaboration At Work

60+

Drug Discovery Programs

Our ecosystem has enabled the industry to view ALS drug development as an increasingly tractable area for investment. Over 60 ALS drug development programs are now in place across the industry as compared to just over five when Target ALS launched.

See How Industry Collaboration Is Making An Impact

12+

Potential New Drugs

Target ALS has helped accelerate the validation of more than 12 therapeutic approaches, which have emerged from funded projects and/or have been informed by our scientific resources and tools.

See What Our Founder Says About Our Progress

5

Drugs Now In Clinical Trials

Since 2013, projects funded by Target ALS have led to clinical trials for five therapeutic approaches. As part of our ongoing efforts, we continue to focus on expanding the drug pipeline, therefore increasing the potential for more trials in the future. 

Footer

  • Challenge
  • Contact
  • Our Approach
  • Resources For Scientists
  • Donate
  • Call For Proposals
  • Funded Consortia
  • Annual Meeting
  • Privacy Policy
  • Credits

Follow Us

guidestar charity-navigator

The Target ALS (TALS) website is intended for informational purposes only. Opinions expressed may not be that of TALS or its employees. For more information about our digital policies, click here.

© 2023 Target ALS Foundation, Inc.
Target ALS Foundation
P.O. Box 1598
New York, NY 10101
(332) 333-4140
Steck Insights WordPress Consulting